STRO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sutro Biopharma Inc

Watchlist Manager

Watchlist

Price: 9.51 USD 4.39% Market Closed

Market Cap: $157.7m

	Sutro Biopharma Inc NASDAQ:STRO	US
	Microstrategy Inc BMV:MSTR	US
V	Vinci SA F:SQUA	FR
	Time Out Group PLC F:05T	UK
	Bank of China Ltd F:W8VS	CN
S	SoftBank Group Corp XMUN:SFT	JP
N	Nokia Oyj PSE:NOKIA	FI

Profitability Summary

Sutro Biopharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-289%

Negative 3Y Average Operating Margin

-160%

Operating Margin is Increasing

-374% > -289%

Negative Net Margin

-395%

Negative 3Y Average Net Margin

-197%

Declining Net Margin

-355% > -395%

Negative Free Cash Flow Margin

-319%

Negative 3Y Average Free Cash Flow Margin

-180%

Free Cash Flow Margin is Increasing

-320% > -319%

Exceptional ROE

267%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-248%

Declining ROIC

-273% > -331%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.